Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
First published online on November 7, 2007
Chest, doi:10.1378/chest.07-2259
A more recent version of this article appeared on January 1, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
chest.07-2259v1
133/1/176    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mussaffi, H.
Right arrow Articles by Blau, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mussaffi, H.
Right arrow Articles by Blau, H.

Induced sputum in the very young: a new key to infection and inflammation

Huda Mussaffi, M.D1,2; Elizabeth M. Fireman, Ph.D3,2; Meir Mei-Zahav, M.D1,2; Dario Prais, M.D1,2 and Hannah Blau, M.B.B.S1,2

1The Pulmonary Unit and the Kathy and Lee Graub Cystic Fibrosis Center, Schneider Children's Medical Center of Israel, Petah Tikva, Israel 2The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel 3National Laboratory Center for Interstitial Lung Diseases, Institute for Pulmonary and Allergic Diseases, Sourasky Medical Center, Tel Aviv, Israel

hblau{at}post.tau.ac.il

Abstract

Background: Chronic inflammation and infection in cystic fibrosis (CF) and other lung diseases begin early, making non-invasive diagnostic techniques vital. As induced sputum (IS) is useful in older patients, we investigated its adaptation to young non-expectorating children.

Methods: Following 4.5% saline inhalation, sputum was collected by naso- or oropharyngeal suction for culture and inflammatory markers, with paired preceding oropharyngeal cough swabs (OCS) in a subgroup. Forty-eight IS procedures (46 successful) from 20 CF children, median age 3y, were compared with 8 specimens from 8 non-CF pulmonary patients, median age 4.5y.

Results: The procedure was safe, SaO2 remaining ≥96%. In CF, 14/46 (30%) cultured P. aeruginosa whereas 19/46 (41%) had no growth. In non-CF, 7/8 cultured bacteria, none P. aeruginosa. Comparing 29 paired IS and OCS: 11 versus 5 cultured P. aeruginosa (not significant) whereas 12 versus 21 had no growth (p=0.02). A correlation was found between independent inflammatory markers neutrophil elastase (NE) and both IL-8 (r=0.85, p< 0.001) and % neutrophils (r=0.35, p<0.05), confirming validity of IS in evaluating early airway disease. IL-8 also increased with age (r=0.41, p<0.05). Inflammation was similar in CF and non-CF subjects.

Conclusions: IS in the young is feasible, safe and clinically useful, and could serve as an outcome measure for new therapies.

Key Words: cystic fibrosis • induced sputum • infection • inflammation • non-expectorating







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American College of Chest Physicians.